Jijun Dong

Company: Salubris Biotherapeutics Inc.

Job title: Chief Scientific Officer

Seminars:

Biparatopic ADCs: Enhancing Binding & Internalization for Improved Cytotoxic Efficacy 11:30 am

Leveraging biparatopic ADCs to enhance drug binding and internalization, leading to improved ADC cytotoxic efficacy Understanding the preclinical safety and efficacy data from Salubris Bio’s lead biparatopic ADC molecule Reviewing translation into the clinic and early clinical experience so farRead more

day: Day One